SARS-CoV-2-IN-61
SARS-CoV-2-IN-61 (compound 8i) is a SARS CoV-2 PLpro inhibitor with an IC50 of 16 µM. SARS-CoV-2-IN-61 has antiviral activities[1].
Product Specifications
CAS Number
[3044004-40-9]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-61.html
Solubility
10 mM in DMSO
Smiles
C[C@@H](NC(C1=CC(C(N(CCC)CCC)=O)=CC=C1)=O)C2=CC=CC3=CC=CC=C32
Molecular Formula
C26H30N2O2
Molecular Weight
402.53
References & Citations
[1]Arun K Ghosh, et al. SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads. Bioorg Med Chem Lett. 2023 Sep 27:96:129489.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6323886-01 0.1 mL
NAT1, ID (NAT1, AAC1, Arylamine N-acetyltransferase 1, Arylamide acetylase 1, Monomorphic arylamine N-acetyltransferase, N-acetyltransferase type 1) (MaxLight 490)
Ask
View Details